UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

Journal of thoracic oncology, 2021-07, Vol.16 (7), p.1200-1210

2021

Volltextzugriff (PDF)

SBRT of Large Tumors: A Retrospective Study

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015-11, Vol.93 (3), p.E481-E482

2015

Volltextzugriff (PDF)

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors

Cancers, 2022-01, Vol.14 (3), p.702

2022

Volltextzugriff (PDF)

HILUS-Retrospective—A Retrospective Toxicity Analysis of Patients Treated with SBRT for Centrally Located Lung Lesions

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017-10, Vol.99 (2), p.E474-E474

2017

Volltextzugriff (PDF)

PO-0665: Radiation induced brachial plexus toxicity after SBRT of apically located lung lesions

Radiotherapy and oncology, 2015-04, Vol.115, p.S324-S325

2015

Volltextzugriff (PDF)

Outcome After SBRT of Adrenal Gland Metastases: A Multicenter Retrospective Analysis of 60 Adrenal Metastases

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014-09, Vol.90 (1), p.S326-S326

2014

Volltextzugriff (PDF)

2383P Stereotactic body radiotherapy (SBRT) of patients with oligometastatic urothelial cancer (UC): A single institution experience

Annals of oncology, 2023-10, Vol.34, p.S1213-S1214

2023

Volltextzugriff (PDF)

Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar)

European journal of radiology, 2024-08, Vol.177, p.111557, Article 111557

2024

Volltextzugriff (PDF)

Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK Inhibition

Clinical lung cancer, 2020-11, Vol.21 (6), p.e544-e546

2020

Volltextzugriff (PDF)

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

Radiation oncology (London, England), 2024-06, Vol.19 (1), p.74-7

2024

Volltextzugriff (PDF)

Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors

International journal of radiation oncology, biology, physics, 2023-12, Vol.117 (5), p.1222-1231

2023

Volltextzugriff (PDF)

Deep learning versus iterative image reconstruction algorithm for head CT in trauma

Emergency radiology, 2022-04, Vol.29 (2), p.339-352

2022

Volltextzugriff (PDF)

Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions

Acta oncologica, 2019-08, Vol.58 (8), p.1178-1186

2019

Volltextzugriff (PDF)

Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Acta oncologica, 2023, Vol.62 (12), p.1921-1930

2023

Volltextzugriff (PDF)

Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage

Molecular oncology, 2021-11, Vol.15 (11), p.2941-2957

2021

Volltextzugriff (PDF)

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden

Lung cancer (Amsterdam, Netherlands), 2018-06, Vol.120, p.75-81

2018

Volltextzugriff (PDF)

Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy

Acta oncologica, 2022-09, Vol.61 (9), p.1116-1120

2022

Volltextzugriff (PDF)

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effects

Acta oncologica, 2021-04, Vol.60 (3), p.305-311

2021

Volltextzugriff (PDF)

Plasma thymidine kinase activity (TKa) as a novel prognostic biomarker in metastatic melanoma

JOURNAL OF CLINICAL ONCOLOGY, 2021, Vol.39 (15_suppl), p.9556-9556

2021

Volltextzugriff (PDF)

Corrigendum to “Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden” [Lung Cancer 120 (June) (2018) 75–81]

Lung cancer (Amsterdam, Netherlands), 2018-09, Vol.123, p.178-179

2018

Volltextzugriff (PDF)

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden (vol 120, pg 75, 2018)

LUNG CANCER, 2018-09, Vol.123, p.178

2018

Volltextzugriff (PDF)

P3.12-17 A Retrospective Study Examining the Role of PET-CT in the 8th TNM Staging System of SCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S976-S976

2018

Volltextzugriff (PDF)

Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy

Physica medica, 2021-08, Vol.88, p.53-64

2021

Volltextzugriff (PDF)

Stereotactic body radiotherapy (SBRT) of patients with oligometastatic urothelial cancer (UC): A single institution experience

ANNALS OF ONCOLOGY, 2023, Vol.34, p.S1213

2023

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(29)
Tagungsberichte
(6)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Medicin Och Hälsovetenskap
(26)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Oncology
(13)
Humans
(10)
Cancer And Oncology
(5)
Cancer Och Onkologi
(5)
Female
(5)
Male
(5)
Radiology, Nuclear Medicine & Medical Imaging
(5)
Melanoma
(4)
Prognosis
(4)
Retrospective Studies
(4)
Adult
(3)
Aged
(3)
Biomarkers
(3)
Hematology, Oncology And Palliative Medicine
(3)
Immune Checkpoint Inhibitors
(3)
Radiology
(3)
Respiratory System
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy

SBRT of Large Tumors: A Retrospective Study

Plasma Thymidine Kinase Activity as a Novel Biomarker in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibitors

HILUS-Retrospective—A Retrospective Toxicity Analysis of Patients Treated with SBRT for Centrally Located Lung Lesions

PO-0665: Radiation induced brachial plexus toxicity after SBRT of apically located lung lesions

Outcome After SBRT of Adrenal Gland Metastases: A Multicenter Retrospective Analysis of 60 Adrenal Metastases

2383P Stereotactic body radiotherapy (SBRT) of patients with oligometastatic urothelial cancer (UC): A single institution experience

Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar)

Primary CNS Metastatic BRAF-mutated Lung Adenocarcinoma With Complete Intracranial Response to BRAF/MEK Inhibition

Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience

Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors

Deep learning versus iterative image reconstruction algorithm for head CT in trauma

Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions

Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability

Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden

Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy

Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effects

Plasma thymidine kinase activity (TKa) as a novel prognostic biomarker in metastatic melanoma

Corrigendum to “Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden” [Lung Cancer 120 (June) (2018) 75–81]

Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden (vol 120, pg 75, 2018)

P3.12-17 A Retrospective Study Examining the Role of PET-CT in the 8th TNM Staging System of SCLC

Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy

Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial

Stereotactic body radiotherapy (SBRT) of patients with oligometastatic urothelial cancer (UC): A single institution experience

Suchergebnisse filtern